Details checkedClinical trial listing onlyCheckedregistry

Prednisone SSNHL steroid study cluster

Also known as: Prednisone oral corticosteroid, Sheba bed-rest SSNHL trial, ECOSUB, NCT00416143, NCT07067801

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Steroid/Anti-inflammatory

Stage

Phase 3

Status

Active

Target Gene

—

Route / Mode

Oral corticosteroid; rescue intratympanic corticosteroid context in ECOSUB

Confidence

82%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

Israel, France

Population

adult, sudden, sensorineural, unilateral, repurposed-drug

Trial IDs

Mechanism

Clinical-study cluster involving oral prednisone/corticosteroids for idiopathic sudden sensorineural hearing loss: an older Sheba bed-rest plus prednisone study with unknown final status and the not-yet-recruiting ECOSUB Phase 3 prednisone-versus-placebo trial.

Indications

Hearing Loss Sensorineural Hearing Loss Sudden Sensorineural Hearing Loss Tinnitus

Notes

Corrected from a single intervention-arm row to a two-study steroid cluster. Because NCT00416143 has unknown final status and NCT07067801 is not yet recruiting, this should be interpreted as institution-led study evidence, not an active commercial prednisone program.

Evidence & Sources

2 structured sources

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, stage, status, route, indications...

IDs: NCT00416143

Open

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, stage, status, route, indications...

IDs: NCT07067801

Open

Key Events

2006-06-01